Individualized Homeopathic Medicines in Stage I Essential Hypertension: A Double-Blind, Randomized, Placebo-Controlled Pilot Trial.
J Altern Complement Med
; 27(6): 515-521, 2021 Jun.
Article
in En
| MEDLINE
| ID: mdl-33760643
ABSTRACT
Objective:
The present study assessed the feasibility of a definitive placebo-controlled trial for evaluating individualized homeopathy (IH) in stage I hypertension (HTN).Design:
Double-blind, randomized (IH 34, placebo 34), placebo-controlled, parallel arms, pilot trial. Settings/Location National Institute of Homoeopathy, India.Subjects:
Patients suffering from stage I HTN.Interventions:
IH and identical-looking placebo. Outcomemeasures:
Feasibility issues, blood pressure (BP) and Measure Yourself Medical Outcome Profile-2 (MYMOP-2) were assessed for 6 months.Results:
The recruitment and retention rates were 44.4% and 85.3%, respectively. Group differences were seemingly higher in the IH group than in the placebo group.Conclusions:
Despite challenges in recruitment, an adequately powered efficacy trial appears feasible in the future.Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Materia Medica
/
Essential Hypertension
Type of study:
Clinical_trials
Limits:
Humans
Country/Region as subject:
Asia
Language:
En
Journal:
J Altern Complement Med
Journal subject:
TERAPIAS COMPLEMENTARES
Year:
2021
Document type:
Article
Affiliation country:
India